Abstract

Recently, there are rumors of a five-way merger between biotechnology companies - Xenova, Oxford Glycosciences, KS Biomedix, Antisoma and, possibly, British Biotech, to create a leader in anticancer therapy - dubbed UK Oncology plc...

This page is available to subscribers only.

Not a subscriber? Join here

Why should I subscribe?

Already Registered? Please login using the top left purple box.

Copyright: © IQVIA 2018